Insider · CIK 0001167028
Patrick W Smith
Files at AXON (AXON ENTERPRISE, INC.), IMDX (Oncocyte Corp). First filing Dec 27, 2024, latest Sep 10, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
AXON: AXON ENTERPRISE, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
IMDX: Oncocyte Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | AXON ENTERPRISE, INC. | $5.1M 10,000 shares | -0% | +46% from low · -35% from high | |
| 30Weak | Oncocyte Corp | $192k 90,219 shares | +5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -71 | $501.99 | $36k | 3,127,941 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -410 | $503.74 | $207k | 3,127,531 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -1,104 | $505.59 | $558k | 3,126,427 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -744 | $506.48 | $377k | 3,125,683 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -749 | $507.48 | $380k | 3,124,934 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -1,774 | $508.45 | $902k | 3,123,160 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -1,319 | $509.32 | $672k | 3,121,841 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -1,348 | $510.59 | $688k | 3,120,493 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -1,251 | $511.43 | $640k | 3,119,242 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -1,033 | $512.70 | $530k | 3,118,209 | 31 d ago |
| Sep 8, 2026 | AXON AXON ENTERPRISE, INC. | SOpen-market sale Common Stock10b5-1 | -197 | $513.38 | $101k | 3,118,012 | 31 d ago |
| Mar 24, 2025 | AXON AXON ENTERPRISE, INC. | AGrant or award Common Stock | +194,030 | $0.00 | $0 | 3,073,982 | Mar 26, 2025 |
| Dec 26, 2024 | IMDX Oncocyte Corp | POpen-market purchase Common Stock, no par valueindirect: See footnote | +90,219 | $2.13 | $192k | 1,773,903 | Dec 27, 2024 |
| Dec 13, 2024 | AXON AXON ENTERPRISE, INC. | GGift Common Stock | -29,531 | $0.00 | $0 | 2,895,529 | Dec 17, 2024 |
| Dec 13, 2024 | AXON AXON ENTERPRISE, INC. | GGift Common Stock | -15,577 | $0.00 | $0 | 2,879,952 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.